CEACAM1 anticorps

N° du produit ABIN114594

Cet anticorps anti-CEACAM1 est un anticorps Souris Monoclonal détectant CEACAM1 dans FACS, IF, EIA et IHC (fro). Adapté pour Humain et Mammifères. Ce Primary Antibody a été cité dans 8+ publications.

Aperçu rapide pour CEACAM1 anticorps (ABIN114594)

Antigène: CEACAM1 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1))

Reactivité: Humain, Mammifères

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CEACAM1 est non-conjugé

Application: Flow Cytometry (FACS), Immunofluorescence (IF), Enzyme Immunoassay (EIA), Immunohistochemistry (Frozen Sections) (IHC (fro))

Clone: 8G5

Détail du produit anti-CEACAM1 anticorps

Specificité: This antibody detects complete native protein expressed on transfected cells.

Purification: Protein G Chromatography

Immunogène: Genetic immunisation with cDNA encoding the extracellular region of Human CEACAM1-A2. Based on recognition of the complete native protein expressed on transfected mammalian cells.

Isotype: IgG1

Information d'application

Indications d'application: Flow cytometry: 1.2 μg/10^6 cellsCompetitive ELISA: 1: 200 - 1: 400. ELISA: 1: 200 - 1: 400. Immunoflourescence. Immunohistology: 10 μg/mL (on cryosections).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Concentration: 1.0 mg/mL

Buffer: PBS, pH 7.2

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store the reconstituted antibody at 2-8 °C for one month (add 0.09% Sodium Azide) or at -20 °C for longer.

Références pour anticorps anti-CEACAM1 (ABIN114594)

Peng, Oberst, Huang, Brohawn, Morehouse, Lekstrom, Baeuerle, Wu, Yao, Coats, DallAcqua, Damschroder, Hammond: "The CEA/CD3-bispecific antibody MEDI-565 (MT111) binds a nonlinear epitope in the full-length but not a short splice variant of CEA." dans: PLoS ONE, Vol. 7, Issue 5, pp. e36412, (2012) (PubMed).

Sémiramoth, Gleizes, Turbica, Sandré, Gorges, Kansau, Servin, Chollet-Martin: "Escherichia coli type 1 pili trigger late IL-8 production by neutrophil-like differentiated PLB-985 cells through a Src family kinase- and MAPK-dependent mechanism." dans: Journal of leukocyte biology, Vol. 85, Issue 2, pp. 310-21, (2009) (PubMed).

Béaslas, Torreilles, Casellas, Simon, Fabre, Lacasa, Delers, Chambaz, Rousset, Carrière: "Transcriptome response of enterocytes to dietary lipids: impact on cell architecture, signaling, and metabolism genes." dans: American journal of physiology. Gastrointestinal and liver physiology, Vol. 295, Issue 5, pp. G942-52, (2008) (PubMed).

Nittka, Böhm, Zentgraf, Neumaier: "The CEACAM1-mediated apoptosis pathway is activated by CEA and triggers dual cleavage of CEACAM1." dans: Oncogene, Vol. 27, Issue 26, pp. 3721-8, (2008) (PubMed).

Thomas, Zhu, Schnaar, Alves, Konstantopoulos: "Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow." dans: The Journal of biological chemistry, Vol. 283, Issue 23, pp. 15647-55, (2008) (PubMed).

Yoon, Terada, Kita: "CD66b regulates adhesion and activation of human eosinophils." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 179, Issue 12, pp. 8454-62, (2007) (PubMed).

Avadhanula, Rodriguez, Devincenzo, Wang, Webby, Ulett, Adderson: "Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner." dans: Journal of virology, Vol. 80, Issue 4, pp. 1629-36, (2006) (PubMed).

Kammerer, Riesenberg, Weiler, Lohrmann, Schleypen, Zimmermann: "The tumour suppressor gene CEACAM1 is completely but reversibly downregulated in renal cell carcinoma." dans: The Journal of pathology, Vol. 204, Issue 3, pp. 258-67, (2004) (PubMed).

Détails sur CEACAM1

Antigène: CEACAM1 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1))

Autre désignation: CD66a / CEACAM1

Sujet: CEACAM1 (BGP/CD66a) is a transmembrane glycoprotein which belongs to the carcinoembryonic antigen (CEA) gene family (1,2). It is expressed on cells of epithelial and myeloid origin and mediates homophilic intercellular interactions that influence cellular growth, immune cell activation, and tissue morphogenesis. CEACAM1 is a putative tumour suppressor based on diminished expression in some aggressive types of cancer cells (3). The anti-tumour effect may be due to inhibition of tumour angiogenesis, possibly by increased secretion of anti-angiogenic molecules from the cells (4). Like all members of the CEACAM family, it consists of a single N domain, with structural homology to the immunoglobulin variable domains, followed by two immunoglobulin constant-like A (A1, A2) and one B domain. While the N, A1 and B domains can also be found in other CEA-family members, the A2 domain of CEACAM1 differs from those found in other CEACAM.Synonyms: BGP, BGP1, Biliary glycoprotein 1, Carcinoembryonic antigen-related cell adhesion molecule 1

ID gène: 634

NCBI Accession: NP_001020083

UniProt: P13688